Home  |  About SITC  |  Facebook  |  Twitter  |  LinkedIn  |  YouTube  |  Oncology Tube  |  Sitemap

Advances in Cancer Immunotherapy™-Chicago, Illinois (May 2015)

Tumor Immunology 101: A Navigation Guide for the Growing
Field of Cancer Immunotherapy


Friday, May 29, 2015
Leading into the ASCO Annual Meeting
8 a.m. - noon
Regency Ballroom AB
Hyatt Regency McCormick Place
, 2nd Floor
2233 South Dr. Martin Luther King Jr. Drive
Chicago, IL 60616

CME- and CNE-certified Advances in Cancer ImmunotherapyTM regional program


Leisha A. Emens, MD, PhD – Johns Hopkins University
John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC

Planning Committee

Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center
Matthew M. Burke, MBA, RN, MSN, APRN-B – Smilow Cancer Hospital at Yale-New Haven
Joseph W. Fay, MD – Baylor University Medical Center
Keith L. Knutson, PhD – Vaccine & Gene Therapy Institute of Florida
Hideho Okada, MD, PhD – University of California San Francisco
John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC
Brian I. Rini, MD – Cleveland Clinic Taussig Cancer Center
Alexander Spira, MD, PhD – Virginia Cancer Specialists
Laura S. Wood, RN, MSN, OCN – Cleveland Clinic Taussig Cancer Center


Specifically designed for clinical oncologists, registered nurses, nurse practitioners, and the entire medical team involved in treating cancer patients with immunotherapy, this introductory, CME- and CNE-certified program provided an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.

Presented by leading authorities in tumor immunology and cancer immunotherapy, this program facilitated understanding of 1) the underlying principles of tumor immunology and immunotherapy, 2) the clinical indications for cancer immunotherapy and appropriate selection of patients, 3) patient management, and 4) the therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes. 

Attendees also took advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.

Intended Audience

The target audience for these programs includes clinical oncologists, registered nurses, nurse practitioners, others involved in patient care, early career individuals, allied health professionals, and patient advocates who wish to learn principles of tumor immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients.

Session Topics

  • Immunology 101 for the Non-Immunologist
  • Basic Principles of Tumor Immunotherapy
  • Basic Mechanisms of Tumor Immune Suppression
  • Cytokines: Interferons, Interleukins and Beyond
  • Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
  • Oncolytic Viruses as Tumor Immunotherapy Agents
  • Current Status of Chimeric and Adoptive T Cell Therapy
  • Is There a Role for Radiation Therapy and Immunotherapy?

Educational Objectives

Upon completion of this program, the participants were able to:

  • Interpret the key principles of tumor immunology and immunotherapy
  • Analyze recent research and clinical applications of cytokines, cancer vaccines, T cell checkpoint inhibitors, adoptive immunotherapy and biomarkers
  • Participate in scientific exchange with local colleagues, potential collaborators, and subject matter experts on research and clinical application of cancer immunotherapy
  • Implement cancer immunotherapy treatments into clinical practice more effectively through a sound understanding of how they work, the clinical management of patients, and the potential to improve patient outcomes with tumor immunotherapy
  • Provide appropriate care and counsel for patients and their families.

Be sure to stop by SITC's exhibit booth – #19064!

Not an official event of the 2015 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the Society for Immunotherapy of Cancer in collaboration with Postgraduate Institute for Medicine

The Advances in Cancer ImmunotherapyTM series is supported in part by independent medical educational grants from:

  • AstraZeneca
  • Bristol-Myers Squibb
  • Genentech
  • Merck & Co., Inc.
  • Novartis Pharmaceuticals Corporation
  • Prometheus Laboratories Inc.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.). Please contact SITC prior to the live event at (414) 271-2456.

View All Advances in Cancer ImmunotherapyTM 2015 Regional Programs

Society for Immunotherapy of Cancer
555 East Wells Street, Suite 1100  |  Milwaukee, WI 53202-3823 USA
Tel: +1 414 271 2456  |  Fax: +1 414 276 3349  |  Email: info@sitcancer.org
About SITC  |  Membership  |  Journal  |  Meetings  |  Resources  |  Support SITC
© 2016 Society for Immunotherapy of Cancer. All rights reserved.